Delve into complex bifurcation PCI with detailed case studies illustrating practical approaches to challenging scenarios, including managing stent loss in stented left main bifurcations. Gain valuable lessons from retrograde CTO-PCI and true bifurcation lesions to enhance your procedural strategies.

Explore advanced techniques and decision-making processes in managing coronary bifurcation lesions. This session covers high-risk PCI in calcified left main bifurcations, distal wire anchoring for angulated vessels, and the use of drug-coated balloons to simplify complex ostial lesions, providing valuable insights for optimizing bifurcation PCI outcomes.

Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

Find out more about a 77-year-old male patient with hypertension without good BP control, dyslipidaemia, Type II-DM, ex-smoker, who had triple CABG in 2006, EF 60% in 2017, and presented with dyspnea. 

Read this new document reflecting the expertise of European operators to promote CTO PCI in Europe and neighbouring communities

SHARE is turning its attention to Mali in West Africa with a view to duplicating the Mauritanian experience. Find our more about how this NGO helps to save lives!

Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...

This image highlights the challenges of managing infective endocarditis (IE) and explores the potential role of transcatheter extraction devices in addressing unmet needs for patients who cannot undergo surgery.

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...

Because of the current COVID-19 environment with an exponential development of ‘digital format of postgraduate learning events’, often on the same topics, it seems essential to remember the foundation of effective post graduate learning in the field of medicine, and how we...

Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission. 

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.